SCHEMBL20827855

SCHEMBL20827855

CC(NC(=O)C(Cc1ccccc1)NC(=O)Cc1ccccc1)C(=O)C(=O)NC(Cc1ccccc1)C(=O)NC(Cc1ccccc1)C(N)=O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTPN1 P18031 4/20 0.60
▸ CTSL P07711 1/20 0.54
▸ CTSB P07858 1/20 0.54
▸ CTSS P25774 1/20 0.54
▸ FCER2 P06734 4/20 0.51
▸ MMP1 P03956 2/20 0.51
▸ PTPN2 P17706 2/20 0.51
▸ REN P00797 1/20 0.50
▸ PTPRA P18433 1/20 0.50
▸ PTPN6 P29350 1/20 0.50
▸ PTPN11 Q06124 1/20 0.50
▸ MMP9 P14780 1/20 0.47
▸ MMP8 P22894 1/20 0.47
▸ MMP14 P50281 1/20 0.47
▸ HRH1 P35367 1/20 0.46
▸ CHRNA1 P02708 1/20 0.46
▸ CHRNG P07510 1/20 0.46
▸ CHRNB1 P11230 1/20 0.46
▸ CHRND Q07001 1/20 0.46
▸ CAPN1 P07384 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20816899 0.96 PTPN1 (0.58) PTPN1CTSLCTSBCTSSFCER2
SCHEMBL20816662 0.96 PTPN1 (0.58) PTPN1CTSLCTSBCTSSFCER2
SCHEMBL20816879 0.96 PTPN1 (0.58) PTPN1CTSLCTSBCTSSFCER2
SCHEMBL20816664 0.96 PTPN1 (0.58) PTPN1CTSLCTSBCTSSFCER2
SCHEMBL20816548 0.93 FCER2 (0.56) PTPN1CTSLCTSBCTSSFCER2
SCHEMBL20816656 0.93 FCER2 (0.56) PTPN1CTSLCTSBCTSSFCER2
SCHEMBL20816767 0.92 PTPN1 (0.62) PTPN1CTSLCTSBCTSSFCER2
SCHEMBL20816766 0.92 PTPN1 (0.62) PTPN1CTSLCTSBCTSSFCER2
SCHEMBL20816877 0.91 PTPN1 (0.56) PTPN1CTSLCTSBCTSSFCER2
SCHEMBL20816696 0.91 PTPN1 (0.56) PTPN1CTSLCTSBCTSSFCER2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190085024-A1 Alpha-Ketoamide Inhibitors Of Cysteine Proteases Phelix Therapeutics (US) 2019-03-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190085024-A1 Alpha-Ketoamide Inhibitors Of Cysteine Proteases CTSS, CTSB, CTSL PTPN1 4631/4885CTSL 3/4885CTSB 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback